Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda

Stopped Because of unexpectedly reduced disease prevalence in the study area, a pragmatic decision was taken to terminate recruitment in March 2003.

Conditions

• Trypanosomiasis, African

Interventions

• DRUG: Eflornithine plus Nifurtimox combination therapy

Sponsor

Epicentre

Collaborators

• [object Object]